A phase 3 trial is the final and most extensive stage of clinical testing for new drugs or treatments before regulatory submission. Conducted on large patient populations, it evaluates safety, efficacy, and optimal dosing, often comparing the new therapy to existing standards of care. Results from phase 3 trials are critical for determining whether a treatment can be approved for public use and can significantly influence pharmaceutical company valuations and healthcare markets.